A recent study from the University of Hong Kong has found that sodium-glucose cotransporter 2 inhibitors (SGLT2i), a new type ...

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...

A new study found that over 800 million adults have diabetes worldwide — almost twice as many as previous estimates have ...

The International Diabetes Federation (IDF) is drawing up new guidelines for the treatment of Type 2 diabetes in consultation with a global expert panel. These guidelines are being evaluated ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

The rise in type 2 diabetes cases globally presents opportunities for growth in the market for GLP-1 drugs like Ozempic and ...

Discover how researchers from PGI and NABI are unlocking the anti-diabetic properties of ginger, leading to innovative ...

The rise in type 2 diabetes has become a significant public health concern in recent years. This form of diabetes happens ...

On Sunday, during November's Diabetes Awareness Month, over 1,500 San Diegans walked to raise money to find a cure at the ...